{"id":"https://openalex.org/W7204708573","doi":"https://doi.org/10.1016/s2152-2650(26)01213-9","title":"POSTER: IBCL-1420: Real-World Inpatient Outcomes Associated With Caplacizumab Use in Immune Thrombotic Thrombocytopenic Purpura: A National Inpatient Sample Analysis","display_name":"POSTER: IBCL-1420: Real-World Inpatient Outcomes Associated With Caplacizumab Use in Immune Thrombotic Thrombocytopenic Purpura: A National Inpatient Sample Analysis","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204708573","doi":"https://doi.org/10.1016/s2152-2650(26)01213-9"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)01213-9","doi":"https://doi.org/10.1016/s2152-2650(26)01213-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01213-9","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5148692777","display_name":"Haider Bin Khalid","orcid":"https://orcid.org/0000-0003-4005-4575","observed_orcids":["https://orcid.org/0000-0003-4005-4575"]},"institutions":[{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Haider Bin Khalid","raw_affiliation_strings":["Geisinger Health System, Wilkes-Barre, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisinger Health System, Wilkes-Barre, PA, USA","institution_ids":["https://openalex.org/I54713919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148682659","display_name":"Saumil ParikhDO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102322142","display_name":"Rutgers, The State University of New Jersey","ror":"https://ror.org/05vt9qd57","country_code":"US","type":"education","lineage":["https://openalex.org/I102322142"]},{"id":"https://openalex.org/I2802498997","display_name":"Jersey City Medical Center","ror":"https://ror.org/01wrc0z23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2802498997"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Saumil ParikhDO","raw_affiliation_strings":["Rutgers-Jersey City Medical Center, Jersey City, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rutgers-Jersey City Medical Center, Jersey City, NJ, USA","institution_ids":["https://openalex.org/I102322142","https://openalex.org/I2802498997"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062644791","display_name":"Dawood Hasan Syed","orcid":"https://orcid.org/0009-0004-4136-3921","observed_orcids":["https://orcid.org/0009-0004-4136-3921"]},"institutions":[{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dawood Hasan Syed","raw_affiliation_strings":["Geisinger Health System, Wilkes-Barre, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisinger Health System, Wilkes-Barre, PA, USA","institution_ids":["https://openalex.org/I54713919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063734992","display_name":"Abisha Phudong","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abisha Phudong","raw_affiliation_strings":["Geisinger Health System, Wilkes-Barre, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisinger Health System, Wilkes-Barre, PA, USA","institution_ids":["https://openalex.org/I54713919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148726448","display_name":"Ahmed Torshani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Torshani","raw_affiliation_strings":["Geisinger Health System, Wilkes-Barre, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisinger Health System, Wilkes-Barre, PA, USA","institution_ids":["https://openalex.org/I54713919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000117943","display_name":"Sudeep Siddappa Malleshappa","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sudeep Siddappa Malleshappa","raw_affiliation_strings":["UMass Chan-Baystate, Springfield, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UMass Chan-Baystate, Springfield, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051501842","display_name":"Ahmad Hanif","orcid":"https://orcid.org/0000-0001-5358-8862","observed_orcids":["https://orcid.org/0000-0001-5358-8862"]},"institutions":[{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmad Hanif","raw_affiliation_strings":["Geisinger Health System, Wilkes-Barre, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisinger Health System, Wilkes-Barre, PA, USA","institution_ids":["https://openalex.org/I54713919"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5137272838","display_name":"Kathan Mehta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I54713919","display_name":"Geisinger Health System","ror":"https://ror.org/02qdbgx97","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I54713919"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathan Mehta","raw_affiliation_strings":["Geisinger Health System, Wilkes-Barre, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisinger Health System, Wilkes-Barre, PA, USA","institution_ids":["https://openalex.org/I54713919"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S321","last_page":"S321"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12352","display_name":"Heparin-Induced Thrombocytopenia and Thrombosis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/caplacizumab","display_name":"caplacizumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/immune-thrombotic-thrombocytopenic-purpura","display_name":"immune-mediated thrombotic thrombocytopenic purpura","score":0.9990000128746033},{"id":"https://openalex.org/keywords/in-hospital-outcomes","display_name":"hospitalization outcomes","score":0.9319999814033508},{"id":"https://openalex.org/keywords/real-world-evidence","display_name":"real-world evidence","score":0.7400000095367432},{"id":"https://openalex.org/keywords/nationwide-inpatient-sample","display_name":"National Inpatient Sample","score":0.6610000133514404},{"id":"https://openalex.org/keywords/thrombotic-microangiopathy","display_name":"thrombotic microangiopathy","score":0.6539999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9679999947547913},{"id":"https://openalex.org/C198531522","wikidata":"https://www.wikidata.org/wiki/Q485146","display_name":"Sample (material)","level":2,"score":0.4869000017642975},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.45329999923706055},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3765000104904175},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.35040000081062317},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34769999980926514},{"id":"https://openalex.org/C129848803","wikidata":"https://www.wikidata.org/wiki/Q2564360","display_name":"Sample size determination","level":2,"score":0.32710000872612},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3125999867916107},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.2948000133037567},{"id":"https://openalex.org/C3018553135","wikidata":"https://www.wikidata.org/wiki/Q67004728","display_name":"Medication adherence","level":2,"score":0.2915000021457672},{"id":"https://openalex.org/C2779159551","wikidata":"https://www.wikidata.org/wiki/Q1414874","display_name":"Comorbidity","level":2,"score":0.2793999910354614},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.275299996137619},{"id":"https://openalex.org/C3020318244","wikidata":"https://www.wikidata.org/wiki/Q4812187","display_name":"Large sample","level":2,"score":0.2547999918460846}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)01213-9","doi":"https://doi.org/10.1016/s2152-2650(26)01213-9","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)01213-9","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2669","issn":["2152-2669","2152-2650"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7204717123","https://openalex.org/W7171759118","https://openalex.org/W7204725173","https://openalex.org/W7204733967","https://openalex.org/W4413810896","https://openalex.org/W4413777389","https://openalex.org/W7204681655","https://openalex.org/W7168124742","https://openalex.org/W7169601701","https://openalex.org/W4388598016"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-31T00:00:00"}